Northern Exposure PR

Our Clients

Client News

16/01/2018 Cambrex and AstraZeneca Hold Ceremony to Mark Long-Term Supply Agreement at Karlskoga, Sweden Facility

30/01/2018 Cambrex Expands Process Research and Development Capabilities Across North America

28/02/2018 Catalent Completes $4.6 Million Expansion at Singapore Clinical Supply Facility

12/04/2018 Catalent Completes $5.5 Million Expansion of Clinical Storage at Philadelphia Facility

17/04/2018 SGS Strengthens Belgian Clinical Pharmacology Unit with Appointment of New Medical Director

17/04/2018 Cambrex Invests in New Continuous Flow Technology at its High Point, NC Facility

21/04/2018 Cambrex Completes New $3.2 Million Analytical Research & Development Laboratory at its High Point, NC Facility

24/04/2018 Catalent To Invest $5 million at Somerset Site to Create New Drug Development and Modified Release Center of Excellence

24/04/2018 SGS H3N2 Challenge Virus Wins the Medicine Maker 2017 Innovation Awards

14/05/2018 Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars

15/05/2018 Cambrex Completes Pilot Plant Expansion at its High Point, NC Facility

17/05/2018 Catalent Completes $5.5 Million Phased Clinical Storage Expansion at Kansas City Campus

31/05/2018 Cambrex Invests $5 Million in New Laboratory Expansion at its Karlskoga, Sweden Facility

31/05/2018 Catalent Biologics Supports InterveXion on New Treatment for Methamphetamine Users

05/06/2018 SGS Quality, Expertise & Reliability Recognized at 2018 CRO Leadership Awards

12/06/2018 Cambrex Expands Generic API Research and Development Capabilities at Milan, Italy Site

13/06/2018 Catalent Appoints Paul Hegwood as New President of Clinical Supply Services

26/06/2018 Catalent Biologics Announces Appointment of Dr. Graham Brearley as General Manager of its Madison, Wisconsin Facility

03/07/2018 Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc.

10/07/2018 Catalent Biologics Adopts Berkeley Lights’ Beacon® Optofluidic Platform to Accelerate Cell Line Development

12/07/2018 Catalent Appoints Marlene Leuenberger as General Manager of New Drug Development Center of Excellence

23/07/2018 Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network

14/08/2018 Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc.

28/08/2018 SGS to Open New Biopharmaceutical Testing Laboratory in Geneva

04/09/2018 SGS Successfully Implements PBMC Analysis for Early Phase Clinical Trials at its Clinical Pharmacology Unit in Antwerp, Belgium

04/09/2018 Aucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent for Vigabatrin Stick Pack Dosage Form

10/09/2018 IDEXX Pseudalert Test Accepted as Global ISO Standard

11/09/2018 New SGS Biopharmaceutical Testing Capabilities in Illinois

12/09/2018 Cambrex Completes Acquisition of Halo Pharma

25/09/2018 Cambrex to Expand and Invest at High Point, NC Site to Create New Center of Excellence for Process Development and Clinical Supply

26/09/2018 Catalent Selected to Provide Oral Delivery Systems for GB Sciences’ Proprietary Parkinson’s Disease Therapies

04/10/2018 Catalent Invests $7.3 Million at its Aprilia, Italy Facility

08/10/2018 Cambrex Invests c.$3 Million to Upgrade Generic API Manufacturing Facilities at Milan, Italy Site

16/10/2018 Catalent and Verastem Oncology Partner on Newly Launched, FDA Approved COPIKTRA™ (duvelisib) Capsules

23/10/2018 SGS Introduces New In vitro Toxicology Testing at its Mississauga, Canada, Laboratory

13/11/2018 Catalent to Open Second Clinical Supply Facility in China

13/11/2018 SGS Expands Elemental Impurity Testing Services at its Laboratory in Chennai, India